Afficher la notice abrégée

dc.contributor.authorOlaechea, Allinson
dc.contributor.authorBenabdellah, Karim
dc.contributor.authorPadial Molina, Miguel 
dc.contributor.authorGalindo Moreno, Pablo Antonio 
dc.date.accessioned2023-10-27T07:53:33Z
dc.date.available2023-10-27T07:53:33Z
dc.date.issued2023-09-16
dc.identifier.citationAllinson Olaechea, Karim Benabdellah, Andrea Vergara-Buenaventura, Sara Gómez-Melero, Emilio A Cafferata, Jonathan Meza-Mauricio, Miguel Padial-Molina, Pablo Galindo-Moreno, Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Review, Stem Cells Translational Medicine, 2023;, szad059, [10.1093/stcltm/szad059]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/85292
dc.description.abstractTissue engineering is a relatively recent research area aimed at developing artificial tissues that can restore, maintain, or even improve the anatomical and/or functional integrity of injured tissues. Otolaryngology, as a leading surgical specialty in head and neck surgery, is a candidate for the use of these advanced therapies and medicinal products developed. Nevertheless, a knowledge-based analysis of both areas together is still needed. The dataset was retrieved from the Web of Science database from 1900 to 2020. SciMAT software was used to perform the science mapping analysis and the data for the biomedical translation identification was obtained from the iCite platform. Regarding the analysis of the cognitive structure, we find consolidated research lines, such as the generation of cartilage for use as a graft in reconstructive surgery, reconstruction of microtia, or the closure of perforations of the tympanic membrane. This last research area occupies the most relevant clinical translation with the rest of the areas presenting a lower translational level. In conclusion, Tissue engineering is still in an early translational stage in otolaryngology, otology being the field where most advances have been achieved. Therefore, although otolaryngologists should play an active role in translational research in tissue engineering, greater multidisciplinary efforts are required to promote and encourage the translation of potential clinical applications of tissue engineering for routine clinical usees_ES
dc.description.sponsorshipUniversidad Peruana de Ciencias Aplicadas, Lima, Perú (UPC-ExPost-2023-2)es_ES
dc.description.sponsorshipThe PECART-0027-2020 (Consejería de Salud y Familias, Junta de Andalucía, Spain)es_ES
dc.description.sponsorshipProyExcel_00875 (Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía, Spain)es_ES
dc.description.sponsorshipResearch Group #CTS-1028 (MP-M and PG-M, Junta de Andalucía, Spain)es_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.rightsAttribution-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nd/4.0/*
dc.subjectCellular therapyes_ES
dc.subjectExtracellular vesicleses_ES
dc.subjectOral mesenchymal stem cellses_ES
dc.subjectBone regenerationes_ES
dc.subjectPreclinical modelses_ES
dc.subjectAngiogenesises_ES
dc.subjectOsteogenesises_ES
dc.subjectProinflammatory cytokineses_ES
dc.titlePreclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Reviewes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1093/stcltm/szad059
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NoDerivatives 4.0 Internacional